Pfizer Inc. PFE

28.67 0.26 0.92% as of 25 Sep
Market cap
$161.7B
P/E
37.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
4.97% 8.28% 8.87% 10.59%

+8 more TTM periods

ROA
2.13% 3.60% 3.69% 4.59%
ROIC
6.30% 6.41% 6.45% 6.13%
Return on Tangible Assets
15.62% 26.87% 30.80% 33.65%
Average Days of Receivables
71.57 72.55 69.26 82.90
Free Cash Flow per Share
1.93 1.67 1.60 1.83
Free Cash Flow
10,985.00 9,483.00 9,075.00 10,376.00
Capital Expenditures
(2,416.00) (2,501.00) (2,629.00) (2,701.00)
Piotroski F-Score
6.00 5.00 6.00 8.00
Other line items
Cash ROIC
8.36% 7.14% 7.09% 7.70%
Accounts Receivable Turnover
5.19 5.18 5.36 4.37
Accounts Payable Turnover
3.51 3.44 2.96 3.23
Inventory Turnover
1.58 1.56 1.49 1.44
Average Days of Payables
97.87 98.07 119.04 109.78
Days of Inventory on Hand
212.48 232.17 242.03 250.59
Tax Rate
0.04 (0.05) 0.04 0.07
Research and Development Expense of Revenue
17.35% 16.94% 16.68% 16.35%
Selling, General and Administrative Expense of Revenue
21.54% 21.68% 22.04% 22.15%
Share Based Compensation of Revenue
1.49% 1.42% 1.28% 1.20%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
3.09 1.60 1.51 1.33
Depreciation/Fixed assets
0.35 0.34 0.34 0.35
Capex/Depreciation
(0.37) (0.38) (0.40) (0.40)
Revenue per Share
11.18 11.13 11.01 11.04
Operating CF per Share
2.35 2.11 2.06 2.30
Capex per Share
(0.42) (0.44) (0.46) (0.48)
Capex to Sales
0.04 0.04 0.04 0.04
Net Profit Margin
6.80% 11.83% 12.42% 15.65%

Fold the line items

Columns are period end dates